Literature DB >> 6407347

Reversed passive hemagglutination and inhibition with Rift Valley fever and Crimean-Congo hemorrhagic fever viruses.

R Swanepoel, J K Struthers, G M McGillivray.   

Abstract

Reversed passive hemagglutination (RPHA) tests were performed by coating glutaraldehyde-fixed and tannic acid-treated sheep erthrocytes with antibodies to Rift Valley fever (RVF) and Crimean-Congo hemorrhagic fever (CCHF) viruses. Cells coated with crude antibody, in the form of mouse immune ascitic fluid, reacted with high specificity and sensitivity in RPHA tests with live or inactivated virus antigens. In inhibition (RPHI) tests, RVF antibody titers in human and sheep sera were similar to those determined by hemagglutination inhibition test. RVF virus antigen could be detected in viremic sheep sera by the RPHA technique. RPHI antibody titers to CCHF virus in human and hare sera were similar to indirect immunofluorescence (IF) titers, but sheep and cattle sera with RPHI titers of 1:32 or less were negative in IF tests.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407347     DOI: 10.4269/ajtmh.1983.32.610

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Rapid diagnosis of human Crimean-Congo hemorrhagic fever and detection of the virus in naturally infected ticks.

Authors:  J F Saluzzo; B Le Guenno
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

2.  Comparison of methods for isolation and titration of Crimean-Congo hemorrhagic fever virus.

Authors:  A J Shepherd; R Swanepoel; P A Leman; S P Shepherd
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

3.  Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Koji Sakai; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 4.  Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.

Authors:  Vanessa N Raabe
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

5.  Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

6.  Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates.

Authors:  F J Burt; R Swanepoel; L E Braack
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

7.  Serodiagnosis of Crimean-Congo haemorrhagic fever.

Authors:  F J Burt; P A Leman; J C Abbott; R Swanepoel
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

8.  Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Viraemic transmission of Crimean-Congo haemorrhagic fever virus to ticks.

Authors:  A J Shepherd; R Swanepoel; S P Shepherd; P A Leman; O Mathee
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

10.  Evaluation of enzyme-linked immunosorbent assay and reversed passive hemagglutination for detection of Crimean-Congo hemorrhagic fever virus antigen.

Authors:  A J Shepherd; R Swanepoel; D E Gill
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.